Immunovia AB (publ) IMMVF
0.00 USD -0.01 (-52.60%)
At close·Nov 5, 2026, 4:00 PM EST
0.00474 52-week range 0.05207
- YTD
- -76.30%
- 1 year
- -90.90%
Altman Z-Score
-64.95 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 1
P/E -0.4×
P/S 92.9×
P/B 1.0×
P/FCF -0.8×
EV/EBITDA 0.2×
EV/Sales -18.9×
FCF Yield -123.2%
Gross Margin 80.3%
Operating Margin -11774.4%
Net Margin -21301.5%
ROE -225.4%
ROIC -110.0%
ROA -165.4%
Revenue -26.6%
Operating Income 26.5%
EPS (diluted) 54.8%
Free Cash Flow 19.2%
Current Ratio 5.1×
Quick Ratio 5.1×
Debt / Equity 0.0×
Net Debt / EBITDA 1.0×
Interest Coverage -1.2×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31